Pozen secures second patent for its drug technology
Research Triangle Park, N.C. — Pozen (Nasdaq: POZN) hasn't gotten any pain relief from the FDA recently - but it has from the U.S. Patent and Trademark Office....
Please Log In to add a comment.
Latest for Insiders
- CEO: Even as WedPics tops 1M weddings, HB2 is hurting biz
- Watch a real red wedding - at Red Hat Summit
- NC Secretary of State praises crowdfunding bill
- Pay, check your heart rate: Chinese smartwatch embeds Valencell biometric sensors
- It's first-and-goal for NC's crowdfunding bill
- 'Sales acceleration' software startup ZynBit lands $500K
- Crowdfunding bill 'down to the 2 yard line;' bitcoin bill advances
- 'Launch Startup in a Day' program aims to cut red tape
- Red Hat to offer employees stock purchase plan as incentive
- Survey: Consumers value accuracy most from wearables